FST and cryohydrocytosis: Therefore, concentrations of activin-A, activin-B, and follistatin in serum samples collected at different times during the treatment protocol for genotypes 1 and 4 were compared with those obtained from healthy and treatment naïve patients with CHC genotypes 1 and 4.